Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Levamisole

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 62Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Changzhou Yabang- QH Pharmachem Co
    China
    		 CHANGZHOU YABANG-QH PHARMACHEM CO., LTD. Chunjiang Town CN CEP 2022-376 - Rev 00 Levamisole Hydrochloride 2024-04-16 Valid Chemical 726
    28/10/2024 Nanjing Pharmaceutical
    China
    		 NANJING WHITE WHALE PHARMACEUTICAL CO., LTD. Nanjing City CN R1-CEP 2013-154 - Rev 01 Levamisole Hydrochloride 2022-06-23 Valid Chemical 726